Concepts (136)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hyperoxaluria, Primary | 1 | 2017 | 25 | 0.560 |
Why?
|
Oxalates | 1 | 2017 | 99 | 0.540 |
Why?
|
Mitotic Index | 1 | 2016 | 162 | 0.520 |
Why?
|
Learning Curve | 1 | 2016 | 232 | 0.460 |
Why?
|
Hepatectomy | 1 | 2016 | 588 | 0.400 |
Why?
|
Kidney Transplantation | 7 | 2017 | 4265 | 0.400 |
Why?
|
Neuroendocrine Tumors | 1 | 2016 | 657 | 0.330 |
Why?
|
Histones | 1 | 2016 | 2603 | 0.250 |
Why?
|
Liver Transplantation | 1 | 2017 | 2403 | 0.240 |
Why?
|
Kidney Failure, Chronic | 1 | 2017 | 2493 | 0.230 |
Why?
|
Laparoscopy | 1 | 2016 | 2055 | 0.230 |
Why?
|
Graft Survival | 5 | 2016 | 3888 | 0.190 |
Why?
|
Graft Rejection | 4 | 2015 | 4492 | 0.190 |
Why?
|
Transplantation, Heterologous | 5 | 2015 | 2395 | 0.180 |
Why?
|
Galactosyltransferases | 4 | 2015 | 284 | 0.180 |
Why?
|
Skin Transplantation | 3 | 2015 | 1097 | 0.180 |
Why?
|
Thymus Gland | 2 | 2016 | 1266 | 0.170 |
Why?
|
Clinical Competence | 1 | 2016 | 4859 | 0.170 |
Why?
|
Immune Tolerance | 4 | 2016 | 2323 | 0.160 |
Why?
|
Pancreatic Neoplasms | 1 | 2016 | 5443 | 0.150 |
Why?
|
Rejuvenation | 2 | 2016 | 110 | 0.150 |
Why?
|
Hyperoxaluria | 1 | 2017 | 33 | 0.140 |
Why?
|
Hematoxylin | 1 | 2016 | 61 | 0.130 |
Why?
|
Eosine Yellowish-(YS) | 1 | 2016 | 70 | 0.130 |
Why?
|
Receptor, Interferon alpha-beta | 1 | 2016 | 113 | 0.120 |
Why?
|
Swine | 8 | 2016 | 5998 | 0.120 |
Why?
|
Major Histocompatibility Complex | 2 | 2015 | 877 | 0.120 |
Why?
|
Bioengineering | 1 | 2014 | 101 | 0.110 |
Why?
|
Receptor, IGF Type 1 | 1 | 2016 | 384 | 0.110 |
Why?
|
Ki-67 Antigen | 1 | 2016 | 628 | 0.110 |
Why?
|
Coloring Agents | 1 | 2016 | 564 | 0.110 |
Why?
|
Swine, Miniature | 4 | 2016 | 965 | 0.100 |
Why?
|
Leuprolide | 1 | 2014 | 313 | 0.100 |
Why?
|
Isoantigens | 1 | 2014 | 562 | 0.100 |
Why?
|
Transplantation Tolerance | 2 | 2014 | 633 | 0.100 |
Why?
|
Blood Loss, Surgical | 1 | 2016 | 643 | 0.100 |
Why?
|
Nephrectomy | 1 | 2017 | 949 | 0.100 |
Why?
|
Interferon-alpha | 1 | 2016 | 910 | 0.100 |
Why?
|
Renal Insufficiency | 1 | 2017 | 812 | 0.090 |
Why?
|
Cytomegalovirus Infections | 2 | 2014 | 839 | 0.090 |
Why?
|
Epidermis | 1 | 2013 | 539 | 0.090 |
Why?
|
Proteinuria | 1 | 2014 | 610 | 0.090 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2014 | 696 | 0.090 |
Why?
|
Isoantibodies | 1 | 2014 | 681 | 0.090 |
Why?
|
Cholangiocarcinoma | 1 | 2015 | 562 | 0.080 |
Why?
|
Bile Duct Neoplasms | 1 | 2015 | 615 | 0.080 |
Why?
|
Chi-Square Distribution | 1 | 2016 | 3438 | 0.080 |
Why?
|
Tissue and Organ Procurement | 2 | 2014 | 986 | 0.080 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2015 | 1363 | 0.080 |
Why?
|
Forkhead Transcription Factors | 1 | 2016 | 1625 | 0.080 |
Why?
|
Leukocytes, Mononuclear | 1 | 2015 | 1855 | 0.080 |
Why?
|
Glomerular Filtration Rate | 1 | 2017 | 2228 | 0.070 |
Why?
|
ROC Curve | 1 | 2016 | 3629 | 0.070 |
Why?
|
Tissue Donors | 2 | 2014 | 2382 | 0.070 |
Why?
|
Renal Dialysis | 1 | 2017 | 1789 | 0.070 |
Why?
|
Time Factors | 4 | 2016 | 40266 | 0.070 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2016 | 2059 | 0.060 |
Why?
|
Linear Models | 1 | 2016 | 5890 | 0.060 |
Why?
|
Bone Marrow | 1 | 2016 | 2935 | 0.060 |
Why?
|
Disease-Free Survival | 1 | 2016 | 6856 | 0.060 |
Why?
|
Kaplan-Meier Estimate | 1 | 2016 | 6546 | 0.060 |
Why?
|
Heart Transplantation | 2 | 2015 | 3301 | 0.060 |
Why?
|
Phosphorylation | 1 | 2016 | 8317 | 0.060 |
Why?
|
Kidney | 2 | 2017 | 7057 | 0.060 |
Why?
|
Histocompatibility | 2 | 2015 | 321 | 0.050 |
Why?
|
Cell Proliferation | 2 | 2016 | 10486 | 0.050 |
Why?
|
Multivariate Analysis | 1 | 2016 | 12093 | 0.050 |
Why?
|
Papio | 2 | 2014 | 672 | 0.050 |
Why?
|
Length of Stay | 1 | 2016 | 6525 | 0.050 |
Why?
|
Attitude of Health Personnel | 1 | 2016 | 3925 | 0.050 |
Why?
|
Survival Rate | 1 | 2016 | 12873 | 0.050 |
Why?
|
Public Health | 1 | 2014 | 2680 | 0.050 |
Why?
|
Logistic Models | 1 | 2016 | 13317 | 0.050 |
Why?
|
Proportional Hazards Models | 1 | 2016 | 12563 | 0.050 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2016 | 4053 | 0.050 |
Why?
|
Female | 8 | 2017 | 397464 | 0.040 |
Why?
|
Melanoma | 1 | 2016 | 5709 | 0.040 |
Why?
|
T-Lymphocytes | 1 | 2014 | 10276 | 0.030 |
Why?
|
Shrews | 1 | 2015 | 7 | 0.030 |
Why?
|
Skin Neoplasms | 1 | 2016 | 5864 | 0.030 |
Why?
|
Disease Models, Animal | 1 | 2015 | 18366 | 0.030 |
Why?
|
Animals | 10 | 2016 | 169408 | 0.030 |
Why?
|
Presumed Consent | 1 | 2014 | 3 | 0.030 |
Why?
|
Male | 8 | 2016 | 365249 | 0.030 |
Why?
|
Papio hamadryas | 1 | 2014 | 32 | 0.030 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2016 | 11886 | 0.030 |
Why?
|
Aged | 3 | 2016 | 171790 | 0.030 |
Why?
|
Cells, Cultured | 3 | 2015 | 19023 | 0.030 |
Why?
|
Flow Cytometry | 2 | 2016 | 5905 | 0.030 |
Why?
|
Valine | 1 | 2016 | 410 | 0.030 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 2015 | 304 | 0.030 |
Why?
|
Aged, 80 and over | 2 | 2016 | 59738 | 0.030 |
Why?
|
Sphingomyelin Phosphodiesterase | 1 | 2014 | 83 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2016 | 15889 | 0.030 |
Why?
|
Histocompatibility Antigens | 1 | 2014 | 479 | 0.030 |
Why?
|
Middle Aged | 3 | 2016 | 223740 | 0.030 |
Why?
|
Adult | 3 | 2016 | 223818 | 0.030 |
Why?
|
Macaca fascicularis | 1 | 2014 | 913 | 0.020 |
Why?
|
Mice, Inbred NOD | 1 | 2016 | 1839 | 0.020 |
Why?
|
Humans | 7 | 2017 | 768887 | 0.020 |
Why?
|
Mutation | 1 | 2016 | 30266 | 0.020 |
Why?
|
Cyclosporine | 1 | 2013 | 777 | 0.020 |
Why?
|
Mice, SCID | 1 | 2016 | 2631 | 0.020 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2014 | 1133 | 0.020 |
Why?
|
Antigens | 1 | 2015 | 1444 | 0.020 |
Why?
|
Glutamic Acid | 1 | 2016 | 1193 | 0.020 |
Why?
|
Retrospective Studies | 2 | 2016 | 81892 | 0.020 |
Why?
|
Podocytes | 1 | 2014 | 403 | 0.020 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2015 | 1105 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2016 | 65485 | 0.020 |
Why?
|
Young Adult | 1 | 2016 | 60110 | 0.020 |
Why?
|
Risk Factors | 1 | 2016 | 74971 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2016 | 1494 | 0.020 |
Why?
|
Creatinine | 1 | 2014 | 1917 | 0.020 |
Why?
|
Gonadotropin-Releasing Hormone | 1 | 2014 | 1149 | 0.020 |
Why?
|
Child | 1 | 2017 | 80969 | 0.020 |
Why?
|
Down-Regulation | 1 | 2016 | 2941 | 0.020 |
Why?
|
Postoperative Care | 1 | 2014 | 1481 | 0.020 |
Why?
|
Aging | 2 | 2016 | 8765 | 0.020 |
Why?
|
Antibodies | 1 | 2014 | 2422 | 0.020 |
Why?
|
Transplantation, Homologous | 1 | 2014 | 4835 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2016 | 11119 | 0.010 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2015 | 4651 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 2013 | 4207 | 0.010 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2013 | 3116 | 0.010 |
Why?
|
Apoptosis | 1 | 2016 | 9528 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2016 | 8664 | 0.010 |
Why?
|
Immunotherapy | 1 | 2015 | 4755 | 0.010 |
Why?
|
Rats | 1 | 2015 | 23847 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2016 | 17174 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2016 | 11684 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2015 | 9264 | 0.010 |
Why?
|
Signal Transduction | 1 | 2016 | 23652 | 0.010 |
Why?
|
Prospective Studies | 1 | 2014 | 54950 | 0.010 |
Why?
|
Mice | 1 | 2016 | 82074 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2014 | 36861 | 0.000 |
Why?
|
Concepts
(136)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(21)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_